← Eichor
Study identifier: NCT06244641 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

New Relapse Model in Psychiatry

Condition: Alcohol Use Disorder  ·  Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

PhaseNA
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn about risk factors of relapse in patients with alcohol use disorder. The main questions it aims to answer are : * Among patients with Alcohol Use Disorder, are there clusters of patients with the same characteristics and the same outcome ? * Which are the risk factors of relapse that are the most predictive ? Do they vary according to cluster? * Can a feedback-measurment-system (eg : a feedback of the tests' results) be usefull in a detoxification unit ? Participants will : * Complete auto-questionnaires * Pass hetero-evaluations * Undergo an electrophysiological battery

This description comes directly from the study's public registry record.

Talk to the study team

Claire Emmanuèle Marie Ledouble  ·  +32474731113  ·  claireledouble@hotmail.com

Philippe de Timary, PhD  ·  +3227642160  ·  philippe.detimary@uclouvain.be

Always discuss trial participation with your own doctor first.

Locations (1)

Cliniques Universitaires Saint-LucBrussels, Brussels Capital, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06244641